About Us Products Research Responsibility Investor Relations Contact Us Search Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies settings, please read our Privacy Policy. By continuing to browse the site, you are agreeing to accept our use of cookies. I Agree INVESTOR RELATIONS In This Section SEC Filings MNK Presentations Calendar of Events RECAST HISTORICAL F/S - AMITIZA TO SPEC BRANDS - 6/27/2019 CLICK HERE NET DEBT LEVERAGE RATIO UPDATE 11/02/2021 CLICK HERE CONTACT INVESTOR RELATIONS investor.relations@mnk.com Daniel J. Speciale Vice President, Finance and Investor Relations Officer Building On Our Heritage More than 150 years of quality, integrity and service. Learn More Our Culture From philanthropic efforts to advocacy initiatives, we are living our values throughout our communities. Learn How Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.© 2021 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Resources For: Career Seekers Investors Suppliers About Mallinckrodt: About Us Home Investor Relations News & Media Products Research Responsibility Other Links: Blog Calif. Supply Chain Disclosure Contact Us Patents Privacy Policy Safety Data Sheets Terms of Use UK Modern Slavery Act Disclosure